IL6 and cancer: Evidence indicates that inflammatory markers, including C reactive protein (CRP) (5), interleukin-6 (IL-6) (6, 7), systemic inflammatory response index (SII) (8), and neutrophil-to-lymphocyte ratio (NLR) (9), are critical factors influencing cancer prognosis.